Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-11

FDA Approved: AKEEGA — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved AKEEGA, a fixed-dose combination of niraparib tosylate monohydrate and abiraterone acetate. This represents an original application for this combin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)
  • Niraparib tosylate monohydrate (niraparib)

Snippet

ORIG AP for AKEEGA (NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE)